上海瑛泰医疗器械股份有限公司（01501）于2026年2月4日发布截至2026年1月31日的月报表。公告披露，报告期内公司完成一宗配售/认购活动，以每股26港元的价格增发3,520万股H股。
该增发使公司H股由1.0421亿股增至1.3941亿股；内资股则维持7,178.66万股不变。截至1月底，公司已发行股本总数达2.112亿股（其中1.3941亿股为H股）。
月报显示，当月无购回、注销或库藏股事项，也无股份期权、可换股票据及其他相关权益的变动。公司声明已遵照香港联交所《上市规则》及相关法律法规，所有发行事项获得董事会正式批准并履行完相关要求。
公告由公司主席兼执行董事梁栋科签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.